CDK6 and breast carcinoma: Moreover, research focusing on genetic epidemiology has uncovered that the host variations in CDK6 contribute to different clinical outcomes among breast cancer patients, which highlights the importance of the study on genetic susceptibility (Dai et al., 2015).